End-of-day quote
Korea S.E.
03:30:00 14/05/2024 am IST
5-day change
1st Jan Change
9,740
KRW
+1.46%
+0.41%
+21.90%
NatureCell Co.,Ltd. announced that it has received KRW 5 billion in funding
On June 29, 2023, NatureCell Co.,Ltd. closed the transaction. The scheduled listing of the share is July 14, 2023 and all new stock is locked up for one year from closing date.
NatureCell Co.,Ltd. announced that it has received KRW 5 billion in funding
29/23/29
CI
NatureCell to Raise 5 Billion Won via Stock Sale
14/23/14
MT
NatureCell Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
13/23/13
CI
NatureCell Co.,Ltd. announced that it has received KRW 11 billion in funding
10/23/10
CI
NatureCell to Raise 11 Billion Won in Stock Sale; Shares Rise 3%
02/23/02
MT
NatureCell Co.,Ltd. announced that it expects to receive KRW 11 billion in funding
02/23/02
CI
NatureCell Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23/23/23
CI
NatureCell Co.,Ltd. announced that it has received KRW 30 billion in funding
20/22/20
CI
NatureCell Co.,Ltd. announced that it expects to receive KRW 30 billion in funding
12/22/12
CI
R Bio Co.,Ltd. agreed to acquire 9.01% stake in NatureCell Co.,Ltd. from Biostar Korea Co., Ltd.
25/21/25
CI
NatureCell Co.,Ltd. announced that it has received KRW 10 billion in funding
26/20/26
CI
NatureCell Co.,Ltd. announced that it expects to receive KRW 10 billion in funding
24/20/24
CI
NatureCell Co.,Ltd. cancelled the acquisition of 2.3% stake in JASC Co., Ltd.
11/19/11
CI
NatureCell Co.,Ltd. agreed to acquire additional 2.3% stake in JASC Co., Ltd. for KRW 1.8 billion.
12/18/12
CI
Nature Cell Starts Commercial Clinical Trials Phase I and II ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer's Disease Treatment in U.S
10/17/10
CI
Nature Cell Co.,Ltd. Receives U.S. FDA Approval for Phase I and II Alzheimer's Clinical Trial
28/16/28
CI
NatureCell Co.,Ltd.(KOSDAQ:A007390) added to S&P Global BMI Index
19/16/19
CI
Nature Cell Co.,Ltd. announced that it has received KRW 5 billion in funding
20/16/20
CI
Nature Cell Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
30/16/30
CI
Sejong Life Science Laboratory sold 0.09% stake in Nature Cell Co.,Ltd. for approximately KRW 230 million.
16/16/16
CI
An unknown buyer acquired 0.07% stake in Nature Cell Co.,Ltd. from Sejong Life Science Laboratory for approximately KRW 180 million.
16/16/16
CI
Biostar Korea Co., Ltd. acquired additional 8.9% stake in Nature Cell Co.,Ltd. from K-STECMCELL Co.,Ltd. for KRW 27 billion.
16/16/16
CI
R Bio Co.,Ltd. announced that it has received KRW 13 billion in funding from NatureCell Co.,Ltd.
22/15/22
CI
K-STECMCELL CO.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Nature Cell Co.,Ltd. and other investors.
20/15/20
CI
Nature Cell Co.,Ltd. announced that it has received KRW 2.3 billion in funding from New Pride Corporation.
13/15/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
NatureCell Co Ltd is a Korea-based company principally engaged in the stem cell business. The Company operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.
More about the company
1st Jan change
Capi.
+21.90% 462M +0.10% 91.42B +2.76% 41.08B -9.06% 34.26B +54.44% 25.27B -16.61% 15.27B -9.14% 12.81B -12.11% 11.6B -43.61% 11.42B +4.49% 9.16B
Biopharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**